Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are both FDA-approved specifically for weight management in adults with obesity or overweight with a weight-related condition regardless of whether diabetes is present
BPC-157 Structure CAS # 137525-51-0 Molecular Formula C62H98N16O22 Molecular Weight 1419.5 PubChem ID 9941957 Sequence GEPPPGKPADDAGLV Research Findings Research involving BPC-157 has focused on its potential role in supporting tissue repair, cellular recovery, and inflammation-related biological pathways
CrossRef GLP-1 Receptor Agonists: Advances in Mechanism, Therapeutic Applications, and Future Perspectives Megha Pawar, Chandrashekhar Patil, Zubershaha Fakir, Durgesh Pagar, Sunil Mahajan BioMed Target Journal.2025
Microcomedones, tiny clogged pores that were already forming beneath your skin's surface, get pushed up faster than they would naturally
However, clinicians should also be aware that some individuals receiving tirzepatide may experience gastrointestinal adverse events, which could possibly lead to discontinuation of treatment
Moreover, GLP-1 and its analogs have shown positive effects in kidney protection, neuroprotection, and lipid metabolism regulation, and they hold promise in treating conditions like non-alcoholic steatohepatitis (NASH) and Alzheimer's disease